|
RIC8B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.38900000001829E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.593710E-04 |
| Normal-vs-Stage2 |
5.110100E-02 |
| Normal-vs-Stage3 |
1.379920E-02 |
| Normal-vs-Stage4 |
2.460200E-01 |
| Stage1-vs-Stage2 |
7.773600E-01 |
| Stage1-vs-Stage3 |
4.800800E-01 |
| Stage1-vs-Stage4 |
7.681600E-01 |
| Stage2-vs-Stage3 |
8.650800E-01 |
| Stage2-vs-Stage4 |
9.198200E-01 |
| Stage3-vs-Stage4 |
9.908600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.91149999998019E-06 |
| Normal-vs-AfricanAmerican |
1.496010E-02 |
| Normal-vs-Asian |
2.784400E-01 |
| Caucasian-vs-AfricanAmerican |
2.214800E-01 |
| Caucasian-vs-Asian |
8.873600E-01 |
| AfricanAmerican-vs-Asian |
7.851000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55599999341183E-09 |
| Normal-vs-Female |
3.621600E-01 |
| Male-vs-Female |
3.245800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.028290E-04 |
| Normal-vs-Extreme_Weight |
1.017880E-03 |
| Normal-vs-Obese |
5.335100E-03 |
| Normal-vs-Extreme_Obese |
3.67390000000078E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.420200E-01 |
| Normal_Weight-vs-Obese |
2.850400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.367000E-01 |
| Extreme_Weight-vs-Obese |
2.724600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.141000E-01 |
| Obese-vs-Extreme_Obese |
2.427200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.561900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.625600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.73310000187266E-08 |
| Normal-vs-Age(81-100Yrs) |
3.16009999945521E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.636600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.568300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.701300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.439700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.858100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.784000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.46369999998175E-06 |
| Normal-VS-Type2 PRCC |
7.74749999710167E-08 |
| Normal-VS-KIRP CIMP |
1.979630E-02 |
| Normal-VS-Unclassified PRCC |
1.920800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.560100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.691800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.737200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.555800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.334400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.659600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60969999996041E-07 |
| Normal-vs-N1 |
2.132200E-01 |
| Normal-vs-N2 |
2.204700E-03 |
| N0-vs-N1 |
2.875500E-02 |
| N0-vs-N2 |
8.957400E-01 |
| N1-vs-N2 |
4.584100E-02 |
|
|
